Background & Sources: Scientific evidence connecting Zantac to Cancer

An organized set of primary and secondary sources covering clinical background, drug-safety signals, and patient-safety considerations.

Primary topic reference

Scientific evidence connecting Zantac to Cancer: Key Facts & Context — detailed background and analysis.

European Medicines Agency (EMA)

Reference: European Medicines Agency (EMA)

Authoritative source for clinical, regulatory, and public-health background reading.

MedlinePlus — Trusted Health Information

Reference: MedlinePlus — Trusted Health Information

Authoritative source for clinical, regulatory, and public-health background reading.

ClinicalTrials.gov

Reference: ClinicalTrials.gov

Authoritative source for clinical, regulatory, and public-health background reading.